BLAUSTEIN MARC (Chief Operating Officer) sold 14.2% of their position (4.62K shares) of FINCH THERAPEUTICS GROUP, INC. on the open market
Open‑market sale worth $1.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/23/2023ACC: 0000899243-23-005985
Officer· Chief Operating Officer
Since Sep 2021
-4.62K
Net shares
Net seller
$1.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.62K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.62K
Price / share
$0.38
Trade value
$1.76K
% of position
14.2%
2/21/2023
32.61K→28K
Total
Net shares
−4.62K
Net value
-$1.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2023 | S · Sale | −4.62K | $0.38 | $1.76K | 14.2% | 32.61K | 28K |
| Total | −4.62K | -$1.76K | ||||||
Derivative Transactions0
No derivative transactions reported